![Phillip Febbo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Febbo
Teknisk/Vetenskaplig/F&U Direktör på
VERACYTE, INC.
Förmögenhet: 6 M $ per 2026-08-31
Profil
Phillip G.
Febbo is currently Director at Acmg Foundation For Genetic & Genomic Medicine, Director at Reagan-udall Foundation since 2021, Chief Scientific & Medical Officer at Veracyte, Inc. since 2023, and Member of the American Society for Clinical Investigation since 2009.
Former positions include Independent Director at Varian Medical Systems, Inc. from 2019 to 2021, Director at Varian, Inc. from 2019 to 2021, Director at American College of Medical Genetics & Genomics from 2018 to 2023, Chief Medical Officer at Illumina, Inc. from 2018 to 2023, Associate Professor at Duke University, Professor at The University of California, San Francisco from 2010 to 2013, and Chief Medical Officer at Genomic Health, Inc. from 2013 to 2018.
Education includes undergraduate degree from Dartmouth College and doctorate from The University of California, San Francisco.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VERACYTE, INC. 0,17 % | 2026-09-04 | 133 048 ( 0,17 % ) | 6 M $ | 2026-08-31 |
Aktiva positioner av Phillip Febbo
| Företag | Position | Start |
|---|---|---|
| VERACYTE, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-10-02 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Företagsledare/Principal | 2009-01-01 |
Acmg Foundation For Genetic & Genomic Medicine
 Acmg Foundation For Genetic & Genomic Medicine Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktör/Styrelseledamot | - |
Reagan-udall Foundation
 Reagan-udall Foundation The Reagan-Udall Foundation is a non-profit company dedicated to advancing regulatory science and innovation. The company is based in Washington, DC. The foundation collaborates with various stakeholders to enhance public health and safety through research and development initiatives. Susan C. Winckler has been the CEO of the company since 2020. | Direktör/Styrelseledamot | 2021-06-01 |
Tidigare kända positioner av Phillip Febbo
| Företag | Position | Slut |
|---|---|---|
| ILLUMINA, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-08-07 |
American College of Medical Genetics & Genomics
 American College of Medical Genetics & Genomics Other Consumer ServicesConsumer Services Functions as a College/University | Direktör/Styrelseledamot | 2023-03-01 |
Varian, Inc.
 Varian, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells scientific instruments & vacuum technology equipment | Direktör/Styrelseledamot | 2021-08-01 |
| VARIAN MEDICAL SYSTEMS, INC. | Direktör/Styrelseledamot | 2021-04-15 |
| GENOMIC HEALTH, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-03-01 |
Phillip Febbos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
63
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Varian, Inc.
Varian, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells scientific instruments & vacuum technology equipment | Health Technology |
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies radiotherapy medical devices for treating cancer & develops related software solutions | Health Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
American College of Medical Genetics & Genomics
American College of Medical Genetics & Genomics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reagan-udall Foundation
Reagan-udall Foundation The Reagan-Udall Foundation is a non-profit company dedicated to advancing regulatory science and innovation. The company is based in Washington, DC. The foundation collaborates with various stakeholders to enhance public health and safety through research and development initiatives. Susan C. Winckler has been the CEO of the company since 2020. | |
Acmg Foundation For Genetic & Genomic Medicine
Acmg Foundation For Genetic & Genomic Medicine Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
